September 23, 2010 by staff
Enfamil, Shares of Mead Johnson Nutrition Company (NYSE: MJN) booked a new 52-week high today and trade above 57.14, traders are definitely monitoring the price action of Mead Johnson to see if this movement attracts more in the purchase of the population.
Mead Johnson Nutrition Company (NYSE: MJN) manufactures nutritional products for infants, children and pregnant and lactating mothers. The company markets its products under the names of Enfamil, Enfalac, Enfapro, Nutramigen, Pregestimil, Enfagrow, EnfaSchool, Enfakid, Sustagen Kid, Lactum, ChocoMilk, Cal-C-Tose, EnfaMama, and expectations LIPIL. Mead Johnson Nutrition operates independently of Bristol-Myers Squibb Co. on December 17, 2009.
Mead Johnson is currently trading 0.6% against the previous close trading session, and estimated support and resistance at 51.14 and 57.14, respectively, and $. It is clear that this action of this range has been penetrated, and traders will be reviewing the price action to establish a new range of tradable
The general market index S & P 500 is trading lower by -0.07% from its close the previous trading, which means that Mead Johnson stock is outpacing the overall market.
Please feel free to send if you have any questions regarding this post , you can contact on
Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.